特発性肺線維症 (IPF)：疫学予測 (～2029年)
Idiopathic Pulmonary Fibrosis - Epidemiology Forecast to 2029
|特発性肺線維症 (IPF)：疫学予測 (～2029年)|
主要7市場における特発性肺線維症 (IPF) の患者総数 (発症者数・有病者数) は、2019年の201,698人から、2029年には237,113人へ増加し、予測期間中は1.76％のAGRが見込まれています。IPFは男性でより一般的であり、IPFの発症者数と有病者数は通常年齢が上がるにつれて増加します。
当レポートでは、特発性肺線維症 (IPF)について調査し、疾病の概要、患者背景、主要7カ国における特発性肺線維症 (IPF)の発症者数・有病者数の予測（今後10年間分）、市場の成長機会などを包括的にまとめています。
Idiopathic pulmonary fibrosis (IPF) is a type of interstitial lung disease and is a serious chronic condition that affects the tissue surrounding the air sacs, or alveoli, in the lungs. This condition occurs when the lung tissue becomes thick and stiff for unknown reasons. Over time, breathing becomes difficult due to fibrosis caused by permanent scarring in the lungs (NHLBI, 2019). IPF is associated with a poor prognosis, with a median survival of three to five years (Raghu et al., 2011). There is currently no cure for IPF. However, certain medicines may slow the progression of IPF, which may extend the lifespan and improve the quality of life for people who have the disease (NHLBI, 2019).
GlobalData epidemiologists utilized county-specific studies published in peer-reviewed journals to build the forecast. GlobalData epidemiologists used sources that confirmed IPF cases through both a biopsy of the lung and high-resolution computed tomography (HRCT). The report includes a 10-year epidemiological forecast for the diagnosed incident and prevalent (total and diagnosed) cases of IPF in the 7MM, segmented by age, sex, severity, and comorbidities.
The following data describes epidemiology of IPF. In the 7MM, GlobalData epidemiologists forecast an increase in the diagnosed incident cases of IPF from 28,301 cases in 2019 to 32,997 cases in 2019, at an AGR of 1.66% over the forecast period. The diagnosed prevalent cases of IPF in the 7MM will increase from 130,822 cases in 2019 to 153,747 cases in 2029, at an AGR of 1.75% over the forecast period. The total prevalent cases of IPF in the 7MM will increase from 201,698 cases in 2019 to 237,113 cases in 2029, at an AGR of 1.76% over the forecast period. IPF is more common in men, and the incidence and prevalence of IPF typically increases with advancing age. These trends are reflected in GlobalData's forecast for the diagnosed incident and prevalent (total and diagnosed) cases for the 7MM.
The Idiopathic Pulmonary Fibrosis Epidemiology series will allow you to -